Birchview Capital, LP Diversified Active

CIK: 0001618205 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 8, 2023

Total Value ($000): $133,414 (100.0% shares, 0.0% debt)

Holdings (54)

BMY BRISTOL-MYERS SQUIBB CO 34.9%
Value ($000) $46,593 Shares 728,585 Est. Cost $44.70 Unrealized +31.9%
PRTA PROTHENA CORP PLC 8.0%
Value ($000) $10,659 Shares 156,111 Est. Cost $39.91 Unrealized +61.6%
NBIX NEUROCRINE BIOSCIENCES INC 6.0%
Value ($000) $7,944 Shares 84,240 Est. Cost $72.40 Unrealized +35.0%
— BIODESIX INC 4.6%
Value ($000) $6,199 Shares 5,039,633 Est. Cost $4.90 Unrealized —
ACAD ACADIA PHARMACEUTICALS INC 4.5%
Value ($000) $5,973 Shares 249,400 Est. Cost $35.16 Unrealized -36.8%
— QUIDELORTHO CORP 4.0%
Value ($000) $5,403 Shares 65,203 Est. Cost $69.01 Unrealized —
ELUT AZIYO BIOLOGICS INC 2.9%
Value ($000) $3,906 Shares 1,655,184 Est. Cost $5.84 Unrealized -64.0%
— IMMUNOGEN INC 2.7%
Value ($000) $3,585 Shares 190,000 Est. Cost $6.13 Unrealized —
UTHR UNITED THERAPEUTICS CORP 2.5%
Value ($000) $3,311 Shares 15,000 Est. Cost $93.09 Unrealized +137.9%
OVV OVINTIV INC 2.4%
Value ($000) $3,205 Shares 84,200 Est. Cost $33.44 Unrealized +8.1%
HROW HARROW HEALTH INC 2.1%
Value ($000) $2,856 Shares 150,000 Est. Cost $6.05 Unrealized +264.0%
PHR PHREESIA INC 1.9%
Value ($000) $2,565 Shares 82,700 Est. Cost $23.06 Unrealized +35.7%
MASI MASIMO CORP 1.9%
Value ($000) $2,514 Shares 15,280 Est. Cost $81.54 Unrealized +113.5%
FHTX FOGHORN THERAPEUTICS INC 1.4%
Value ($000) $1,864 Shares 264,843 Est. Cost $19.16 Unrealized -63.5%
— INHIBRX INC 1.4%
Value ($000) $1,829 Shares 70,448 Est. Cost $31.33 Unrealized —
— ACCELERATE DIAGNOSTICS INC 1.4%
Value ($000) $1,824 Shares 2,252,388 Est. Cost $19.28 Unrealized —
ALKS ALKERMES PLC 1.2%
Value ($000) $1,565 Shares 50,000 Est. Cost $21.00 Unrealized +44.2%
ATEC ALPHATEC HOLDINGS INC 1.1%
Value ($000) $1,438 Shares 80,000 Est. Cost $9.84 Unrealized +58.3%
— EQUITRANS MIDSTREAM CORPORATIO 1.0%
Value ($000) $1,272 Shares 133,050 Est. Cost $8.31 Unrealized —
CORT CORCEPT THERAPEUTICS INC 0.8%
Value ($000) $1,113 Shares 50,000 Est. Cost $6.85 Unrealized +235.8%
APLS APELLIS PHARMACEUTICALS INC 0.8%
Value ($000) $1,093 Shares 12,000 Est. Cost $37.18 Unrealized +132.1%
— SOLENO THERAPEUTICS INC 0.8%
Value ($000) $1,052 Shares 245,127 Est. Cost $0.69 Unrealized —
PTGX PROTAGONIST THERAPEUTICS INC 0.8%
Value ($000) $1,050 Shares 38,000 Est. Cost $38.07 Unrealized -34.3%
DCGO DOCGO INC 0.8%
Value ($000) $1,031 Shares 110,000 Est. Cost $7.69 Unrealized +14.1%
— IVERIC BIO INC 0.7%
Value ($000) $984 Shares 25,000 Est. Cost $16.94 Unrealized —
STOK STOKE THERAPEUTICS INC 0.7%
Value ($000) $904 Shares 85,000 Est. Cost $13.12 Unrealized -18.9%
VTYX VENTYX BIOSCIENCES INC 0.6%
Value ($000) $866 Shares 26,400 Est. Cost $22.39 Unrealized +54.0%
— BLUEBIRD BIO INC 0.6%
Value ($000) $820 Shares 249,200 Est. Cost $18.01 Unrealized —
CYTK CYTOKINETICS INC 0.6%
Value ($000) $816 Shares 25,000 Est. Cost $27.06 Unrealized +36.7%
— PIONEER NATURAL RESOURCES CO 0.6%
Value ($000) $787 Shares 3,800 Est. Cost $145.33 Unrealized —
TXG 10X GENOMICS INC 0.5%
Value ($000) $670 Shares 12,000 Est. Cost $36.27 Unrealized +49.2%
— SILK ROAD MEDICAL INC 0.5%
Value ($000) $650 Shares 20,000 Est. Cost $37.42 Unrealized —
TVTX TRAVERE THERAPEUTICS INC 0.5%
Value ($000) $614 Shares 40,000 Est. Cost $20.49 Unrealized -11.2%
— 2SEVENTY BIO INC 0.5%
Value ($000) $606 Shares 59,833 Est. Cost $19.43 Unrealized —
— CHINOOK THERAPEUTICS INC 0.4%
Value ($000) $576 Shares 15,000 Est. Cost $0.02 Unrealized —
— KARYOPHARM THERAPEUTICS INC 0.4%
Value ($000) $521 Shares 291,332 Est. Cost $13.49 Unrealized —
— KINIKSA PHARMACEUTICALS LTD 0.3%
Value ($000) $422 Shares 30,000 Est. Cost $13.10 Unrealized —
XENE XENON PHARMACEUTICALS INC 0.3%
Value ($000) $385 Shares 10,000 Est. Cost $30.24 Unrealized +31.4%
ARVN ARVINAS INC 0.3%
Value ($000) $372 Shares 15,000 Est. Cost $16.46 Unrealized +56.2%
AXGN AXOGEN INC 0.3%
Value ($000) $365 Shares 40,000 Est. Cost $9.32 Unrealized 0.0%
HALO HALOZYME THERAPEUTICS INC 0.3%
Value ($000) $361 Shares 10,000 Est. Cost $51.20 Unrealized -33.4%
KALV KALVISTA PHARMACEUTICALS INC 0.3%
Value ($000) $360 Shares 40,000 Est. Cost $18.69 Unrealized -50.7%
PGNY PROGYNY INC 0.3%
Value ($000) $354 Shares 9,000 Est. Cost $33.03 Unrealized +9.3%
FOLD AMICUS THERAPEUTICS INC 0.3%
Value ($000) $352 Shares 28,000 Est. Cost $14.56 Unrealized -18.5%
XNCR XENCOR INC 0.2%
Value ($000) $307 Shares 12,300 Est. Cost $15.78 Unrealized +72.4%
SRPT SAREPTA THERAPEUTICS INC 0.2%
Value ($000) $286 Shares 2,500 Est. Cost $100.79 Unrealized +27.8%
KROS KEROS THERAPEUTICS INC 0.2%
Value ($000) $281 Shares 7,000 Est. Cost $46.71 Unrealized -6.2%
CGEM CULLINAN ONCOLOGY INC 0.2%
Value ($000) $270 Shares 25,114 Est. Cost $40.60 Unrealized -73.8%
IFRX INFLARX NV 0.2%
Value ($000) $223 Shares 50,000 Est. Cost $3.70 Unrealized +20.9%
BCRX BIOCRYST PHARMACEUTICALS INC 0.1%
Value ($000) $141 Shares 20,000 Est. Cost $6.02 Unrealized +33.4%
GOSS GOSSAMER BIO INC 0.1%
Value ($000) $119 Shares 99,088 Est. Cost $10.02 Unrealized -87.6%
— G1 THERAPEUTICS INC 0.1%
Value ($000) $100 Shares 40,000 Est. Cost $33.05 Unrealized —
— YIELD10 BIOSCIENCE INC 0.0%
Value ($000) $42 Shares 18,750 Est. Cost $6.02 Unrealized —
— NEKTAR THERAPEUTICS 0.0%
Value ($000) $16 Shares 28,000 Est. Cost $15.38 Unrealized —